161 related articles for article (PubMed ID: 30847632)
1. Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2.
Kumar MS; R A; Bhaskaran S; D DR; Nair AS; R SP
J Mol Model; 2019 Mar; 25(4):88. PubMed ID: 30847632
[TBL] [Abstract][Full Text] [Related]
2. Computational and in vitro insights on snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T
J Biomol Struct Dyn; 2018 Dec; 36(16):4197-4208. PubMed ID: 29171346
[TBL] [Abstract][Full Text] [Related]
3. Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies.
Chinnasamy S; Chinnasamy S; Nagamani S; Muthusamy K
J Biomol Struct Dyn; 2015; 33(7):1516-27. PubMed ID: 25192471
[TBL] [Abstract][Full Text] [Related]
4. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
[TBL] [Abstract][Full Text] [Related]
5.
S S; V S; I JM; P VM; P LK; Nair AS; R SP; Oommen OV
J Biomol Struct Dyn; 2023; 41(16):7874-7883. PubMed ID: 36153001
[TBL] [Abstract][Full Text] [Related]
6. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
Chinnasamy S; Chinnasamy S; Muthusamy K
J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
[TBL] [Abstract][Full Text] [Related]
7. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
8. In silico molecular interaction analysis of LTNF peptide-LT10 with snake venom enzymes.
Chavan SG; Deobagkar DD
Protein Pept Lett; 2014 Jul; 21(7):646-56. PubMed ID: 24654849
[TBL] [Abstract][Full Text] [Related]
9. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
Pereañez JA; Patiño AC; Núñez V; Osorio E
Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
[TBL] [Abstract][Full Text] [Related]
10. Conservation analysis and decomposition of residue correlation networks in the phospholipase A2 superfamily (PLA2s): Insights into the structure-function relationships of snake venom toxins.
Oliveira A; Bleicher L; Schrago CG; Silva Junior FP
Toxicon; 2018 May; 146():50-60. PubMed ID: 29608922
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of bioactive compounds of Clematis gouriana Roxb. ex DC against snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T; Chinnasamy S
J Biomol Struct Dyn; 2017 Jul; 35(9):1936-1949. PubMed ID: 27355444
[TBL] [Abstract][Full Text] [Related]
12. A novel synthetic quinolinone inhibitor presents proteolytic and hemorrhagic inhibitory activities against snake venom metalloproteases.
Baraldi PT; Magro AJ; Matioli FF; Marcussi S; Lemke N; Calderon LA; Stábeli RG; Soares AM; Correa AG; Fontes MR
Biochimie; 2016 Feb; 121():179-88. PubMed ID: 26700145
[TBL] [Abstract][Full Text] [Related]
13. Quercetin-3-O-rhamnoside from Euphorbia hirta protects against snake Venom induced toxicity.
Gopi K; Anbarasu K; Renu K; Jayanthi S; Vishwanath BS; Jayaraman G
Biochim Biophys Acta; 2016 Jul; 1860(7):1528-40. PubMed ID: 27033089
[TBL] [Abstract][Full Text] [Related]
14. Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.
Carvalho BM; Santos JD; Xavier BM; Almeida JR; Resende LM; Martins W; Marcussi S; Marangoni S; Stábeli RG; Calderon LA; Soares AM; Da Silva SL; Marchi-Salvador DP
Biomed Res Int; 2013; 2013():153045. PubMed ID: 24171158
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction.
Ticli FK; Hage LI; Cambraia RS; Pereira PS; Magro AJ; Fontes MR; Stábeli RG; Giglio JR; França SC; Soares AM; Sampaio SV
Toxicon; 2005 Sep; 46(3):318-27. PubMed ID: 15992846
[TBL] [Abstract][Full Text] [Related]
16. A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.
Anilkumar NC; Sundaram MS; Mohan CD; Rangappa S; Bulusu KC; Fuchs JE; Girish KS; Bender A; Basappa ; Rangappa KS
PLoS One; 2015; 10(7):e0131896. PubMed ID: 26196520
[TBL] [Abstract][Full Text] [Related]
17. Vanillin analog--vanillyl mandelic acid, a novel specific inhibitor of snake venom 5'-nucleotidase.
Arun R; Arafat AS; D'Souza CJ; Sivaramakrishnan V; Dhananjaya BL
Arch Pharm (Weinheim); 2014 Sep; 347(9):616-23. PubMed ID: 25042467
[TBL] [Abstract][Full Text] [Related]
18. Using yeast two-hybrid system and molecular dynamics simulation to detect venom protein-protein interactions.
Jia Y; Kowalski P; Lopez I
Curr Res Toxicol; 2021; 2():93-98. PubMed ID: 34345854
[TBL] [Abstract][Full Text] [Related]
19. The Natural Ligand for Metalloproteinase-A Multifaceted Drug Target.
Shivashankar S; Sangeetha MK
Appl Biochem Biotechnol; 2022 Apr; 194(4):1716-1739. PubMed ID: 34997448
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet aggregation activity of two novel acidic Asp49-phospholipases A
Sobrinho JC; Kayano AM; Simões-Silva R; Alfonso JJ; Gomez AF; Gomez MCV; Zanchi FB; Moura LA; Souza VR; Fuly AL; de Oliveira E; da Silva SL; Almeida JR; Zuliani JP; Soares AM
Int J Biol Macromol; 2018 Feb; 107(Pt A):1014-1022. PubMed ID: 28951306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
